Clinical trial
Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of…
NCT00088738 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00088738 |
|---|---|
| Title | Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors With [18F]SPA-RQ |
| Official title | Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors With [18F] SPA-RQ |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Panic Disorder, Healthy |
| Intervention type | Drug |
| Interventions | [18F] SPA-RQ |
| Enrollment | 84 |
| Start date | Jul 27, 2004 |
| Completion | Sep 10, 2008 |
| First posted | Aug 2, 2004 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: